Who has invested in GenSight Biologics?

Versant Ventures, Abingworth, Index Ventures are named among the investors backing GenSight Biologics.

GenSight Biologics Funding: $264M Raised, Investors & Rounds

GenSight Biologics funding overview

GenSight Biologics is based in Paris, France. GenSight Biologics has raised $264M in total disclosed funding. That places its disclosed total in the $250M–$1B range. The round record for GenSight Biologics runs through 2025; nothing later has been disclosed. Investors on record include Versant Ventures, Abingworth, Index Ventures. 3 distinct backers are named across the disclosed rounds.

GenSight Biologics at a glance

Total raised: $264M
Latest round date: September 2025
Headquarters: Paris, France
Notable investors: Versant Ventures, Abingworth, Index Ventures

Frequently asked about GenSight Biologics funding

How much has GenSight Biologics raised?: GenSight Biologics has raised $264M in total disclosed funding across the rounds on record.
Who has invested in GenSight Biologics?: Versant Ventures, Abingworth, Index Ventures are named among the investors backing GenSight Biologics.
What was the latest GenSight Biologics funding round?: No round stage has been disclosed for GenSight Biologics.
Where is GenSight Biologics based?: GenSight Biologics is based in Paris, France.
When did GenSight Biologics last raise?: The last disclosed GenSight Biologics round closed in September 2025.

Totals shown for GenSight Biologics aggregate every disclosed round on file. To see how that compares, browse the companies in Paris and the investors behind them below.

GenSight Biologics Funding: $264M Raised, Investors & Rounds

GenSight Biologics funding overview

GenSight Biologics at a glance

Frequently asked about GenSight Biologics funding

Companies related to GenSight Biologics (36)

Browse related funding lists (7)